This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Index levels provide context for technical signals, helping traders confirm trends and anticipate reactions to key thresholds. This intro ties level data to chart patterns.
18,759 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
A Virginia federal judge denied Zillow and Redfin’s bid to dismiss the FTC antitrust lawsuit, keeping the case alive ...
Rising internal strife and political pressure push the FDA toward leadership change, with markets watching how the ag...
Nexxn (NEXN) 2026 earnings signal how the company is navigating growth, profitability, and capital allocation. This g...
ZachXBT alleges insider control as LAB token scrutiny rises amid an investigation into AI Terminal's $6 billion FDV p...
California Governor Gavin Newsom unveils a $350 billion budget designed to erase deficits, broaden reserves, and prot...
Lime’s IPO plans put micro-mobility in the spotlight. This article explains why a seasoned investor might prefer an e...
Greg Abel, stepping into Warren Buffett's shadow, has quietly tripled Berkshire's Alphabet stake. Is this the kind of...
Domain Money is expanding as investors seek integrated, CFP-guided planning powered by AI tools amid market volatilit...
A new Milken-Harris poll shows 80% of Americans want government-backed AI workforce programs now, with 68% feeling th...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
SoFi has surprised some investors by turning a key profitability metric into a clear strength. This article breaks do...